Guerbet has announced that SeQure and DraKon, the company’s two novel microcatheters used in peripheral embolization procedures have received the CE mark for the delivery of intra-arterial therapy and embolic materials into all peripheral vessels.
The SeQure microcatheter is an innovative reflux control microcatheter that uses flow dynamics to create a fluid barrier designed to deliver more treatment to the target vessel and reduce the risk of non-target embolization, for reduced potential damage to surrounding tissue. The catheter consists of side slits whose size has been specifically designed to allow the outflow of contrast media, creating a fluid barrier around the microcatheter to reduce microspheres reflux and assist delivery to the target vessel.
The DraKon peripheral microcatheter is the same as SeQure but without the side slits. It has been designed to optimize pushability, flexibility and torqueability for improved trackability and highest performance standards.
”Guerbet is expanding its interventional portfolio with new solutions for interventionalists, to further enhance and secure their embolization cases. This new range of microcatheters will allow us to help the interventional radiology community deliver a higher quality of care during image-guided embolization procedures,” commented Thomas Bonnefont, VP Commercial Interventional Imaging.
Guerbet
Villepinte, France